Comparative long-term outcomes of first-line CDK4/6 inhibitors plus endocrine therapy versus endocrine therapy in patients with HR+/HER2-metastatic or advanced breast cancer: a meta-analysis

ABSTRACT:

SUBMITTER: Wang X 

PROVIDER: S-EPMC12331727 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature